Xeris Biopharma (XERS) - Net earnings per share (EPS TTM)

Symbol and logo of brand xerispharma.com (XERS)

Xeris Biopharma focuses on developing convenient drug delivery systems for patients with rare pathologies. High supply chain reliability and temperature control guarantee product quality, while its status as an innovator strengthens physician trust. The rolling net income per share demonstrates efficient capital management, with -0.05 recorded as the baseline value for current yield.

XERS (xerispharma.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/17/2026

Comprehensive metric breakdowns and analytics for Xeris Biopharma Inc (XERS)

- share price and expert price forecast:
General company analysis:xerispharma.com (XERS)
Mass-produced product of Xeris Biopharma Holdings, Inc.

High capacity utilization of Xeris Biopharma pharmaceutical facilities directly impacts net income, which is allocated per common share to assess the real return on equity. The current value of -0.05 reflects the final annual financial result stripped of market noise, allowing the annual net income per share trend to differentiate sustainable business growth from temporary fluctuations.

Competitors of Xeris Biopharma (XERS)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio)|Earnings per share for the last twelve months bgm.ltd (BGM)|COGT (Cogent Biosciences Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Keros Therapeutics, Inc. KROS|ARCT (Arcturus Pharma) - Earnings per one share for the last 12 months|Eton Pharmaceuticals - Net earnings per share (EPS TTM)|Earnings per share for the trailing year KMDA (Kamada Ltd.)|FULC: Net earnings per share (EPS TTM)|Abeona (ABEO) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months mereobiopharma.com|Net earnings per share for the last 12 months Protalix (PLX)|Earnings per share for the last twelve months Pliant Therapeutics Inc (PLRX)|Net earnings per share for the last 12 months Applied Therapeutics, Inc. APLT|Net earnings per share (EPS TTM) RNTX (aileronrx.com)|Net earnings per share (EPS TTM) Gelteq Limited Inc GELS|Aytu BioPharma, Inc. - Net earnings per share (EPS TTM)|chemomab.com (CMMB) - Net earnings per share for the last 12 months|SRx Health (SRXH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Polyrizon Ltd. (PLRZ)|Net earnings per share for the last 12 months AEZS|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)